Kalinovskii AP - Search Results

1

Retinoic Acid-Differentiated Neuroblastoma SH-SY5Y Is an Accessible In Vitro Model to Study Native Human Acid-Sensing Ion Channels 1a (ASIC1a).

Kalinovskii AP, Osmakov DI, Koshelev SG, Lubova KI, Korolkova YV, Kozlov SA, Andreev YA. Kalinovskii AP, et al. Biology (Basel). 2022 Jan 20;11(2):167. doi: 10.3390/biology11020167. Biology (Basel). 2022. PMID: 35205034 Free PMC article.

2

Lignans as Pharmacological Agents in Disorders Related to Oxidative Stress and Inflammation: Chemical Synthesis Approaches and Biological Activities.

Osmakov DI, Kalinovskii AP, Belozerova OA, Andreev YA, Kozlov SA. Osmakov DI, et al. Among authors: kalinovskii ap. Int J Mol Sci. 2022 May 27;23(11):6031. doi: 10.3390/ijms23116031. Int J Mol Sci. 2022. PMID: 35682715 Free PMC article. Review.

3

TRPV3 Ion Channel: From Gene to Pharmacology.

Kalinovskii AP, Utkina LL, Korolkova YV, Andreev YA. Kalinovskii AP, et al. Int J Mol Sci. 2023 May 11;24(10):8601. doi: 10.3390/ijms24108601. Int J Mol Sci. 2023. PMID: 37239947 Free PMC article. Review.

4

Dual Modulator of ASIC Channels and GABA_A Receptors from Thyme Alters Fear-Related Hippocampal Activity.

Kalinovskii AP, Pushkarev AP, Mikhailenko AD, Kudryavtsev DS, Belozerova OA, Shmygarev VI, Yatskin ON, Korolkova YV, Kozlov SA, Osmakov DI, Popov A, Andreev YA. Kalinovskii AP, et al. Int J Mol Sci. 2023 Aug 24;24(17):13148. doi: 10.3390/ijms241713148. Int J Mol Sci. 2023. PMID: 37685955 Free PMC article.

5

Opioid Analgesic as a Positive Allosteric Modulator of Acid-Sensing Ion Channels.

Osmakov DI, Onoprienko LV, Kalinovskii AP, Koshelev SG, Stepanenko VN, Andreev YA, Kozlov SA. Osmakov DI, et al. Among authors: kalinovskii ap. Int J Mol Sci. 2024 Jan 24;25(3):1413. doi: 10.3390/ijms25031413. Int J Mol Sci. 2024. PMID: 38338690 Free PMC article.

6

Natural Inhibitors of Mammalian α-Amylases as Promising Drugs for the Treatment of Metabolic Diseases.

Kalinovskii AP, Sintsova OV, Gladkikh IN, Leychenko EV. Kalinovskii AP, et al. Int J Mol Sci. 2023 Nov 20;24(22):16514. doi: 10.3390/ijms242216514. Int J Mol Sci. 2023. PMID: 38003703 Free PMC article. Review.

7

Control of postprandial hyperglycemia by oral administration of the sea anemone mucus-derived α-amylase inhibitor (magnificamide).

Sintsova O, Popkova D, Kalinovskii A, Rasin A, Borozdina N, Shaykhutdinova E, Klimovich A, Menshov A, Kim N, Anastyuk S, Kusaykin M, Dyachenko I, Gladkikh I, Leychenko E. Sintsova O, et al. Biomed Pharmacother. 2023 Dec;168:115743. doi: 10.1016/j.biopha.2023.115743. Epub 2023 Oct 18. Biomed Pharmacother. 2023. PMID: 37862974 Free article.

8

Magnificamide Is a New Effective Mammalian α-Amylase Inhibitor.

Sintsova OV, Leychenko EV, Gladkikh IN, Kalinovskii AP, Monastyrnaya MM, Kozlovskaya EP. Sintsova OV, et al. Among authors: kalinovskii ap. Dokl Biochem Biophys. 2019 Nov;489(1):385-387. doi: 10.1134/S1607672919060097. Epub 2020 Mar 4. Dokl Biochem Biophys. 2019. PMID: 32130606

9

Magnificamide, a β-Defensin-Like Peptide from the Mucus of the Sea Anemone Heteractis magnifica, Is a Strong Inhibitor of Mammalian α-Amylases.

Sintsova O, Gladkikh I, Kalinovskii A, Zelepuga E, Monastyrnaya M, Kim N, Shevchenko L, Peigneur S, Tytgat J, Kozlovskaya E, Leychenko E. Sintsova O, et al. Mar Drugs. 2019 Sep 21;17(10):542. doi: 10.3390/md17100542. Mar Drugs. 2019. PMID: 31546678 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page